Lateral Flow Device Pilot and Development Activity Tender - 144231745

Procurement Summary

Country: United Kingdom

Summary: Lateral Flow Device Pilot and Development Activity

Deadline: 15 Jul 2026

Posting Date: 30 Jun 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 144231745

Document Ref. No.: C388724

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33141625 - Diagnostic kits
73100000 - Research and experimental development services
73111000 - Research laboratory services
73120000 - Experimental development services

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

The UK Health Security Agency (UKHSA) is inviting suppliers to participate in this pre-market engagement exercise for the Lateral Flow Device (LFD) pilot and development activity. This work supports UKHSA-s broader strategy to strengthen the UK-s ability to understand, prevent, and respond to health threats, as set out in the UKHSA Strategy 2026-2029. It also aligns with the UK-s commitment to the 100 Days Mission, which aims to enable the rapid development and deployment of diagnostics, therapeutics, and vaccines within 100 days of identifying a new pandemic threat. A key objective of this programme is to develop resilient, scalable UK-based manufacturing capability for LFDs, reducing reliance on international supply chains and improving national biosecurity. For the purposes of this exercise, UK-based manufacturing refers to the ability to undertake core stages of assay development, device manufacture, and final assembly within the UK, supported by a robust and scalable supply chain. Suppliers are not required to have a fully domestic supply chain but must demonstrate transparency, resilience, and the ability to sustain production at scale during an outbreak. LFDs, particularly antigen-based LFDs, were a key component of large-scale population testing during the COVID-19 response and are expected to play a similarly critical role in future pandemic testing strategies. However, lessons learned from COVID-19 highlighted challenges relating to test quality and performance, the...

Documents

 Tender Notice